Royal Capital Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$976K Hold
2,774
0.61% 33
2025
Q4
$908K Buy
2,774
+1
+0% +$317 0.54% 34
2025
Q3
$783K Sell
2,773
-150
-5% -$43.5K 0.48% 37
2025
Q2
$816K Hold
2,923
0.54% 33
2025
Q1
$911K Hold
2,923
0.64% 33
2024
Q4
$762K Sell
2,923
-213
-7% -$63.2K 0.53% 35
2024
Q3
$1.01M Sell
3,136
-127
-4% -$41.5K 0.71% 31
2024
Q2
$1.02M Sell
3,263
-246
-7% -$72.3K 0.77% 29
2024
Q1
$998K Sell
3,509
-2,131
-38% -$624K 0.78% 31
2023
Q4
$1.62M Buy
5,640
+141
+3% +$38.4K 1.41% 18
2023
Q3
$1.48M Sell
5,499
-125
-2% -$31.2K 1.42% 22
2023
Q2
$1.25M Sell
5,624
-107
-2% -$24.8K 1.18% 25
2023
Q1
$1.39M Sell
5,731
-175
-3% -$43K 1.4% 22
2022
Q4
$1.55M Sell
5,906
-36
-0.6% -$9.65K 1.65% 18
2022
Q3
$1.34M Buy
5,942
+16
+0.3% +$3.88K 1.56% 21
2022
Q2
$1.44M Sell
5,926
-45
-0.8% -$11K 1.56% 22
2022
Q1
$1.44M Sell
5,971
-13
-0.2% -$2.99K 1.41% 22
2021
Q4
$1.35M Buy
+5,984
New +$1.26M 1.31% 25

Other funds holding AMGN

Royal Capital Wealth Management's AMGN Position: Q1 2026 in Review

Royal Capital Wealth Management held its Amgen (AMGN) position steady in Q1 2026 at 2,774 shares worth $976K. The position accounts for 0.61% of the portfolio, ranked #33.

Royal Capital Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.62M in Q4 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Royal Capital Wealth Management held 2,774 shares of Amgen worth $976K as of Q1 2026.
  • Royal Capital Wealth Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.61% of Royal Capital Wealth Management's portfolio in Q1 2026, its #33 holding.
  • Royal Capital Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Royal Capital Wealth Management's Amgen position peaked at $1.62M in Q4 2023.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Royal Capital Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.